GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SQI Diagnostics Inc (FRA:XSQ) » Definitions » LT-Debt-to-Total-Asset

SQI Diagnostics (FRA:XSQ) LT-Debt-to-Total-Asset : 1.87 (As of Mar. 2023)


View and export this data going back to 2010. Start your Free Trial

What is SQI Diagnostics LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. SQI Diagnostics's long-term debt to total assests ratio for the quarter that ended in Mar. 2023 was 1.87.

SQI Diagnostics's long-term debt to total assets ratio increased from Mar. 2022 (0.26) to Mar. 2023 (1.87). It may suggest that SQI Diagnostics is progressively becoming more dependent on debt to grow their business.


SQI Diagnostics LT-Debt-to-Total-Asset Historical Data

The historical data trend for SQI Diagnostics's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SQI Diagnostics LT-Debt-to-Total-Asset Chart

SQI Diagnostics Annual Data
Trend Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.49 0.01 0.61 0.51 0.90

SQI Diagnostics Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 0.49 0.90 1.06 1.87

SQI Diagnostics LT-Debt-to-Total-Asset Calculation

SQI Diagnostics's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Sep. 2022 is calculated as

LT Debt to Total Assets (A: Sep. 2022 )=Long-Term Debt & Capital Lease Obligation (A: Sep. 2022 )/Total Assets (A: Sep. 2022 )
=6.378/7.053
=0.90

SQI Diagnostics's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2023 is calculated as

LT Debt to Total Assets (Q: Mar. 2023 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2023 )/Total Assets (Q: Mar. 2023 )
=5.005/2.679
=1.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SQI Diagnostics  (FRA:XSQ) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


SQI Diagnostics LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of SQI Diagnostics's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


SQI Diagnostics (FRA:XSQ) Business Description

Traded in Other Exchanges
N/A
Address
36 Meteor Drive, Toronto, ON, CAN, M9W 1A4
SQI Diagnostics Inc is the leader in the field of lung health. The company develops and manufactures respiratory health and precision medicine tests that run on SQI's automated systems. The company is developing tests to simplify and improve COVID-19 antibody monitoring, rapid acute lung injury testing, donor organ transplant informatics, and immunological protein and antibody testing. Its geographical segments are the United States, Canada, and Europe. Canada accounts for more than half of its revenues.

SQI Diagnostics (FRA:XSQ) Headlines

No Headlines